Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ACRES Commercial Realty D Pref | ACR-D | Aug 30, 2024 | 23.28 | -0.51 |
Acri Capital Acquisition Unit | ACACU | Aug 30, 2024 | 12.16 | -5.74 |
Acrivon Therapeutics | ACRV | Aug 30, 2024 | 9.49 | -4.91 |
Actelis Networks | ASNS | Aug 30, 2024 | 1.72 | -4.44 |
Actinium Pharmaceuticals | ATNM | Aug 30, 2024 | 1.99 | +4.19 |
Active Bear ETF | HDGE | Aug 30, 2024 | 19.03 | -0.52 |
Active U.S. Real Estate Powershares | PSR | Aug 30, 2024 | 96.05 | +0.96 |
Actuate Therapeutics | ACTU | Aug 30, 2024 | 8.05 | 0.00 |
Acuity Brands | AYI | Aug 30, 2024 | 254.70 | +1.95 |
Acumen Pharmaceuticals | ABOS | Aug 30, 2024 | 2.74 | -2.49 |
Acurx Pharmaceuticals | ACXP | Aug 30, 2024 | 2.20 | -0.45 |
Acushnet | GOLF | Aug 30, 2024 | 66.99 | -0.45 |
ACV Auctions A | ACVA | Aug 30, 2024 | 18.71 | +2.41 |
ACWI Ex-US Index MSCI Ishares | ACWX | Aug 30, 2024 | 55.75 | +0.14 |
ACWI Index MSCI Ishares | ACWI | Aug 30, 2024 | 116.98 | +0.71 |
Adagene ADR | ADAG | Aug 30, 2024 | 2.80 | -3.45 |
Adagio Medical | ADGM | Aug 30, 2024 | 5.15 | 0.00 |
Adamas One | JEWL | Aug 30, 2024 | 0.40 | -10.01 |
Adams Diversified Equity Fund | ADX | Aug 30, 2024 | 21.38 | +0.75 |
Adams Natural Resources Fund | PEO | Aug 30, 2024 | 23.47 | +0.30 |
Adams Resources & Energy | AE | Aug 30, 2024 | 24.00 | -0.48 |
AdaptHealth | AHCO | Aug 30, 2024 | 10.99 | -0.72 |
Adaptimmune Therapeutics ADR | ADAP | Aug 30, 2024 | 1.27 | 0.00 |
Adaptive Biotechnologies | ADPT | Aug 30, 2024 | 4.70 | +0.64 |
ADC Therapeutics SA | ADCT | Aug 30, 2024 | 2.90 | +1.05 |
Addentax Group | ATXG | Aug 30, 2024 | 0.55 | -3.59 |
Addex Therapeutics ADR | ADXN | Aug 30, 2024 | 10.86 | +6.16 |
Addus HomeCare | ADUS | Aug 30, 2024 | 133.01 | +1.47 |
Adecoagro | AGRO | Aug 30, 2024 | 11.01 | +1.66 |
Adeia | ADEA | Aug 30, 2024 | 12.60 | +1.45 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.